Post-COVID Cardiovascular Complications including Vaccine-Related Cardiovascular Effects

Dear Colleagues, 

One of the most important effects of COVID-19 infection is on the cardiovascular system. The cardiovascular consequences of COVID-19 can extend beyond acute infection. Patients may continue to have lingering cardiopulmonary symptoms even after the acute phase of the COVID-19 infection is resolved. It is still not clear whether routine screenings to detect cardiovascular abnormality in COVID-19 patients will be helpful. Additionally, recently, after the availability of the COVID-19 vaccine, cases of myopericarditis have been reported. Though there are not enough data so far to detect the causal relationship of the vaccine and cardiovascular effect, this is a potential field for further research.

We hope to attract the following research to our Special Issue: (1) up to date data regarding the long-term effects of COVID-19 infection on the cardiovascular system; (2) use of advanced diagnostic modalities to detect cardiovascular abnormality associated with prior COVID-19 infection; (3) vaccine-related effects on the cardiovascular system

Various newer diagnostic modalities, including the use of the artificial intelligence, in diagnosing the cardiovascular abnormalities in COVID-19 have emerged. Different medications have comoe out, with promising results in COVID-19 patients; at the same time, cardiac effects of anti-COVID-19 drugs have been discussed. COVID-19 vaccines have already started changing the epidemiology of the infection, reducing the infection rate.

In this issue, we are expecting papers which will provide data about the long-term cardiovascular effects of COVID-19 infection. Additionally, we are looking for papers that can enlighten us about the potential screening guidelines to follow up with COVID-19 patients. We would like to invite authors’ views on COVID-19 vaccine-related cardiovascular effects. 

Dr. Adrija Hajra
Dr. Dhrubajyoti Bandyopadhyay
Dr. Raktim K. Ghosh
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 1800 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• COVID-19
• long term
• cardiovascular
• COVID-19 vaccines